EIB ORION
February 1st, 2005
BY KEITH NUTHALL
THE EUROPEAN Investment Bank (EIB) has drawn up plans to lend Finland pharmaceutical company the Orion Corporation up to Euro 150 million for its research into medicines for central nervous system problems, cardiovascular diseases and hormonal therapies. The bank is supporting the Espoo-based company's work, under its Innovation 2010 Initiative fostering innovation and research.
THE EUROPEAN Investment Bank (EIB) has drawn up plans to lend Finland pharmaceutical company the Orion Corporation up to Euro 150 million for its research into medicines for central nervous system problems, cardiovascular diseases and hormonal therapies. The bank is supporting the Espoo-based company's work, under its Innovation 2010 Initiative fostering innovation and research.
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.